NANOSONO

Active Antimicrobial Protection

Industrial Technologies
Private

Company Overview

Snapshot

Founded in January 2015, NANOSONO operates with 11–50 employees. The company has successfully raised $16 million across 5 funding rounds from 2 investors. In December 2022, NANOSONO secured a significant investment from Gadot Group, highlighting continued investor confidence in its antimicrobial technology platform.

Business overview

NANOSONO is a biotechnology company specializing in an antimicrobial platform that enables surfaces to continuously destroy bacteria. The company's core technology integrates nanotechnology to transform various materials into an "antimicrobial firewall" that remains active permanently, eliminating the need for re-coating. This always-on antimicrobial shield is applicable across a wide range of industries and markets, including healthcare, pharmaceuticals, and industrial manufacturing, with products like Q-Paint, Q-Fabric, and QDERMA.

Strategic signal

In December 2022, NANOSONO secured a $2 million investment from Gadot Group, a strategic move that signals strong validation for its antimicrobial technology. This funding is poised to accelerate the development and market penetration of its nanotechnology-based solutions, indicating a positive trajectory for commercial expansion and product innovation in the industrial technologies sector.

Company Intelligence Q&A

What is NANOSONO's core technology?
NANOSONO develops an antimicrobial platform that uses nanotechnology to create an "antimicrobial firewall" on surfaces, enabling them to continuously destroy bacteria without the need for re-application. This technology is integrated into products like Q-Paint, Q-Fabric, and QDERMA.
When was NANOSONO founded?
NANOSONO was founded in January 2015.
How much capital has NANOSONO raised to date?
NANOSONO has raised a total of $16 million across 5 funding rounds.
Which investor participated in NANOSONO's December 2022 funding round?
In December 2022, NANOSONO received a $2 million investment from Gadot Group, a strategic move that signals strong validation for its antimicrobial technology.
What markets does NANOSONO's technology serve?
NANOSONO's antimicrobial technology serves global markets, with applications across various industries including healthcare, pharmaceuticals, and industrial manufacturing, targeting medical devices, life sciences, and process industries like coatings.

External links